By THE ASSOCIATED PRESS
Federal health regulators have approved Vyvanse, an attention-deficit disorder drug, for a new use as a first-of-its kind treatment for binge-eating disorder.
Published: January 31, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1tHx4Pp
from WordPress http://ift.tt/1BBIW36
via Hadi Aboukhater
No comments:
Post a Comment